Thorvardur Halfdanarson

Papers authored by Thorvardur Halfdanarson

This paper is available in a repository.

2014 Jennifer A. Schlichting, Michelle A. Mengeling

, Nader M. Makki, Ashish Malhotra, Thorvardur R. Halfdanarson

, J. Stacey Klutts

, Barcey T. Levy, Peter J. Kaboli, Mary E. Charlton

Increasing Colorectal Cancer Screening in an Overdue Population: Participation and Cost Impacts of Adding Telephone Calls to a FIT Mailing Program

Download from www.ncbi.nlm.nih.gov

This paper was not found in any repository, but could be made available legally by the author.

Mary E. Charlton, Karyn Beth Stitzenberg, Chi Lin, Grelda Yazmin Juarez, Thorvardur Ragnar Halfdanarson

, Jane F. Pendergast, Elizabeth A. Chrischilles, Robert B. Wallace

Long-term quality of life (QoL) for stage II/III rectal cancer survivors in the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS).

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Ramesh K. Ramanathan, Solomon I. Hamburg, Thorvardur R. Halfdanarson

, Mitesh J. Borad, Mahesh Seetharam, Kelly K. Curtis, Peter Lee, Paul Fredlund, Mark Gilbert, Sean C. Semple, Adam D., Brynne Crowell, Linda Vocila, Ian MacLachlan, Donald W. Northfelt

A Phase I/II Dose Escalation Study of TKM-080301, a RNAi Therapeutic Directed Against PLK1, in Patients with Advanced Solid Tumors, with an Expansion Cohort of Patients with NET or ACC

Upload

Nancy Sharma, Miriam B. Zimmerman, David L. Bushnell, Thomas M. O'Dorisio, Suzanne Kiefer, Thorvardur R. Halfdanarson

Is Renal Toxicity From Y-90 DOTATOC Dependent Upon Dose per PRRT Treatment?

Upload

2013 Mary E. Charlton, Chi Lin, Dingfeng Jiang, Karyn B. Stitzenberg, Thorvardur R. Halfdanarson

, Jane F. Pendergast, Elizabeth A. Chrischilles, Robert B. Wallace

Factors Associated With Use of Preoperative Chemoradiation Therapy for Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium

Download from www.ncbi.nlm.nih.gov

This paper is made freely available by the publisher.

Mary E. Charlton, Michelle A. Mengeling

, Thorvardur R. Halfdanarson

, Nader M. Makki, Ashish Malhotra, J. Stacey Klutts

, Barcey T. Levy, Peter J. Kaboli

Evaluation of a Home-Based Colorectal Cancer Screening Intervention in a Rural State

Download from api.wiley.com

T. R. Halfdanarson

, R. Pannala

Incretins and risk of neoplasia

Download from dx.doi.org

Elizabeth A. Chrischilles, Taher Abu Hejleh, Knute D. Carter, Jane F. Pendergast, Thorvardur Ragnar Halfdanarson

, Robert H. Fletcher, Robert B. Wallace

Comorbidity and survival for patients with advanced-stage non-small cell lung cancer.

Upload

Mary C. Schroeder, Yu-Yu Tien, Thorvardur Ragnar Halfdanarson

, Taher Abu Hejleh, Matthew Nattinger, John Brooks

Geographic variation in the adjuvant treatment of NSCLC over time.

Upload

Thorvardur R. Halfdanarson

, Sigurdis Haraldsdottir, Mitesh J. Borad

Advances in systemic therapy for advanced pancreatobiliary malignancies

Download from dx.doi.org

Judith A. Gilbert, Laura J. Adhikari

, Ricardo V. Lloyd, Thorvardur R. Halfdanarson

, Michael H. Muders, Matthew M. Ames

Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors

Download from www.ncbi.nlm.nih.gov

J. L. Welsh, B. A. Wagner, T. J. van’t Erve, P. S. Zehr, D. J. Berg, T. R. Halfdanarson

, N. S. Yee, K. L. Bodeker, J. Du, L. J. Roberts, J. Drisko, M. Levine, G. R. Buettner, J. J. Cullen

Pharmacological Ascorbate with Gemcitabine for the Control of Metastatic and Node-Positive Pancreatic Cancer (PACMAN): Results from a Phase I Clinical Trial

Download from www.ncbi.nlm.nih.gov

2012 Nitin A. Pagedar, Thorvardur R. Halfdanarson

, Lucy H. Karnell, Henry T. Hoffman, Gerry F. Funk

Upper Aerodigestive Tract Cancer in Patients With Chronic Lymphocytic Leukemia

Upload

Thorvardur R. Halfdanarson

, Axel Grothey

Establishing a Standard of Care for Small Bowel Adenocarcinomas: Challenges and Lessons Learned

Download from theoncologist.alphamedpress.org

Eric Steven Engelman, Roberto Leon-Ferre, Boris G. Naraev, Nancy Sharma, Anna M. Button, Gideon Zamba, Shiliang Sun, Thomas M. O'Dorisio, Thorvardur Ragnar Halfdanarson

Clinical outcomes and predictive value of chromogranin A (CgA) and pancreastatin (PcSt) in liver-directed therapies (LDTs) for well-differentiated metastatic neuroendocrine tumors.

Upload

James A. Kuzman, Boris G. Naraev, Anna M. Button, Megan I. Samuelson, Michael J. Goodheart, Barry DeYoung, Thomas M. O'Dorisio, Thorvardur Ragnar Halfdanarson

Expression of vascular endothelial growth factor receptor (VEGF-R) and CD31 receptor (CD31-R) in high-grade neuroendocrine carcinoma of the uterine cervix (cNEC) and its association with prognosis.

Upload

Boris Naraev, Nancy Sharma, Eric Steven Engelman, David L. Bushnell, Thomas M. O'Dorisio, Thorvardur Ragnar Halfdanarson

The outcome of peptide receptor radionuclide therapy (PRRT) in North American patients with advanced well-differentiated neuroendocrine tumors (WD-NETs).

Upload

Thorvardur Ragnar Halfdanarson

, William R. Bamlet, Robert R. McWilliams, Timothy J. Hobday, Patrick A. Burch, Gloria M. Petersen

Risk factors for sporadic pancreatic neuroendocrine tumors (PNETs): Updated results from a single-center case control study.

Upload

Taher Abu-Hejleh, James J. Mezhir, Michael J. Goodheart, Thorvardur R. Halfdanarson

Incidence and Management of Gastrointestinal Perforation from Bevacizumab in Advanced Cancers

Upload

Boris Naraev, Nancy Sharma, Eric Steven Engelman, David L. Bushnell, Thomas M. O'Dorisio, Thorvardur Ragnar Halfdanarson

The use of peptide receptor radionuclide therapy in patients with metastatic low-grade neuroendocrine tumors.

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Thorvardur Halfdanarson